Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
OTRK 
Ontrak Inc (OTRK)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/02/2025: OTRK (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $3
1 Year Target Price $3
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -69.51% | Avg. Invested days 11 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/02/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 0.43M USD | Price to earnings Ratio - | 1Y Target Price 3 |
Price to earnings Ratio - | 1Y Target Price 3 | ||
Volume (30-day avg) 1 | Beta 1.53 | 52 Weeks Range 0.05 - 3.98 | Updated Date 09/15/2025 |
52 Weeks Range 0.05 - 3.98 | Updated Date 09/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -17.02 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -274.2% | Operating Margin (TTM) -290.04% |
Management Effectiveness
Return on Assets (TTM) -53.8% | Return on Equity (TTM) -215.66% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 5837958 | Price to Sales(TTM) 0.04 |
Enterprise Value 5837958 | Price to Sales(TTM) 0.04 | ||
Enterprise Value to Revenue 0.57 | Enterprise Value to EBITDA -0.36 | Shares Outstanding 7084540 | Shares Floating 1783644 |
Shares Outstanding 7084540 | Shares Floating 1783644 | ||
Percent Insiders 34.42 | Percent Institutions 18.62 |
Upturn AI SWOT
Ontrak Inc
Company Overview
History and Background
Ontrak, Inc. (formerly Catasys, Inc.) was founded in 2003. It focused on using AI and telehealth to manage chronic diseases and improve health outcomes. It experienced rapid growth and significant challenges, including client losses and financial instability, ultimately leading to its downfall and delisting.
Core Business Areas
- Behavioral Health Management: Ontrak offered programs designed to address behavioral health issues, such as depression, anxiety, and substance use disorders, particularly in the context of chronic disease management.
- Chronic Disease Management: The company provided solutions to manage chronic conditions, like diabetes and heart disease, by integrating behavioral health interventions with medical care.
- AI-Powered Platform: Ontrak utilized an AI-powered platform to identify individuals at risk and personalize interventions, aiming to improve health outcomes and reduce healthcare costs.
Leadership and Structure
Ontrak's leadership team consisted of executives in areas such as healthcare, technology, and finance. The organizational structure included departments focused on clinical operations, technology development, sales, and marketing.
Top Products and Market Share
Key Offerings
- Ontrak Program: Ontraku2019s flagship program offered personalized, integrated behavioral health and chronic disease management support. Market share information is not available as the company is effectively defunct. Competitors included companies offering similar telehealth-based chronic disease management solutions like Livongo (now part of Teladoc), Omada Health, and Vida Health.
Market Dynamics
Industry Overview
The telehealth and chronic disease management market is large and growing, driven by increasing healthcare costs, rising prevalence of chronic diseases, and technological advancements. There is significant competition, with many players offering a variety of solutions.
Positioning
Ontrak positioned itself as an AI-driven solution for integrated behavioral health and chronic disease management. However, it struggled to maintain its position due to client losses and financial difficulties.
Total Addressable Market (TAM)
The total addressable market for chronic disease management and behavioral health solutions is estimated to be in the billions of dollars. Ontrak aimed to capture a portion of this market by offering a comprehensive and personalized approach but failed to deliver on this promise and lost significant TAM positioning.
Upturn SWOT Analysis
Strengths
- AI-powered platform for personalized interventions
- Integrated behavioral health and chronic disease management approach
- Telehealth delivery model for increased accessibility
Weaknesses
- Client concentration risk
- High customer churn
- Financial instability and cash flow problems
- Questionable AI efficacy claims
Opportunities
- Expanding telehealth adoption
- Growing demand for chronic disease management solutions
- Partnerships with healthcare providers and payers
Threats
- Increased competition from established players
- Changes in healthcare regulations and reimbursement models
- Data privacy and security concerns
Competitors and Market Share
Key Competitors
- TDOC
- OMAD
- LVGO
- VRDN
Competitive Landscape
Ontrak faced intense competition from established telehealth and chronic disease management companies. Its inability to retain clients and achieve profitability made it difficult to compete effectively.
Growth Trajectory and Initiatives
Historical Growth: Ontrak experienced rapid revenue growth initially, but this growth was unsustainable due to client concentration and high churn.
Future Projections: Future projections are not applicable as Ontrak is no longer a viable business entity.
Recent Initiatives: Recent initiatives prior to the company's struggles included efforts to expand its telehealth platform and forge new partnerships with healthcare providers.
Summary
Ontrak Inc. was a telehealth company focused on behavioral health and chronic disease management that ultimately failed. Although its AI-powered platform and integrated approach were promising, high client churn, financial instability, and competition led to its downfall. The company struggled to achieve profitability and retain clients, resulting in its delisting and near bankruptcy. Ontrak highlights the risks associated with client concentration and the challenges of competing in the rapidly evolving telehealth market.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC filings (historical)
- Company press releases (historical)
- Market research reports (historical)
- News articles
Disclaimers:
This analysis is based on publicly available information and represents a historical overview of Ontrak Inc. Given the company's current state, the information should be interpreted with caution. Market share estimates are approximate and based on available data before the company's near demise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Ontrak Inc
Exchange NASDAQ | Headquaters Miami, FL, United States | ||
IPO Launch date 2013-06-06 | CEO - | ||
Sector Healthcare | Industry Health Information Services | Full time employees 104 | Website https://ontrakhealth.com |
Full time employees 104 | Website https://ontrakhealth.com | ||
Ontrak, Inc. operates as a value-based behavioral healthcare company in the United States. The company's program predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care and treatment they need. Its technology-enabled solutions are designed to provide healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The company's solution includes Wholehealth+ that enables identifying, engaging, and treating these members through its technology-enabled program that focuses on the intersection between behavioral health, physical health, and social health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. is headquartered in Miami, Florida. LD Acquisition Holdings, Inc. On August 29, 2025, Ontrak, Inc. along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.